RACGP rejects pathologists’ PSA screening advice

THE RACGP is sticking to its stance that PSA tests are unsuitable for prostate cancer screening, despite a second professional college moving to recommend their use in men from the age of 40 years.

The Royal College of Pathologists of Australasia (RCPA) will release a position statement next month advising that men seeking to assess their risk should be offered a PSA test and digital rectal examination.

This would provide a “baseline measure” and would be “predictive of future risk”, according to an editorial by RCPA president Dr Paul McKenzie in the college journal, Pathology.

“Our policy statement doesn’t go into whether or not screening is a good idea,” Dr McKenzie said.

“What we’re trying to do is establish a rational application of PSA testing to detect early prostate cancer should people want to use it for that.”

The RACGP said in a statement it would assess new